Plastic surgeons say business is booming as users of obesity drugs reassess how they look.
From school meals to food labelling standards, contributors to our mini-series on Cayman's obesity crisis highlight a range ...
Weight-loss drugs such as Ozempic have been a breakthrough because ... These drugs are believed to have contributed to the first decrease in US obesity rates in more than a decade.
Novo Nordisk boasts 45 million customers using its drug, which has caused a revolution in weight-loss treatment. But competitors are nipping at its heels.
An obesity medicine physician writes that weight-loss drugs such as Ozempic have been getting a bad rap, almost as if those ...
Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...
Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...
Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...
A rising number of people have accepted GLP-1s as a way to treat obesity, which affects more than 100 million Americans.
Novo expects to continue to grow its reach in 2025, though perhaps not at the magnitude witnessed in 2024. For the full year to come, Novo Nordisk is eyeing sales growth at constant currencies between ...
Eli Lilly and Novo Nordisk have both assuaged investor concerns over near-term growth. Now the focus shifts back to their ...
A gut microbe has been identified that mimics the effects of Ozempic to mitigate diabetes and obesity. Here's how to take ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results